The polymorphism of CLOCK gene rs4864548 A>G is associated with susceptibility of Alzheimer’s disease in Chinese population

References

• Cai H, Cong WN, Ji S, Rothman S, Maudsley S, Martin B. 2012. Metabolic dysfunction in Alzheimer’s disease and related neurodegenerative disorders. Curr Alzheimer Res. 9:5–17.10.2174/156720512799015064
   PubMed Web of Science ®Google Scholar
• Cardinal P, Bellocchio L, Clark S, Cannich A, Klugmann M, Lutz B, Marsicano G, Cota D. 2012. Hypothalamic CB1 cannabinoid receptors regulate energy balance in mice. Endocrinology. 153:4136–4143.10.1210/en.2012-1405
   PubMed Web of Science ®Google Scholar
• Chartier-Harlin MC, Parfitt M, Legrain S, Pérez-Tur J, Brousseau T, Evans A, Berr C, Vidal O, Roques P, Gourlet V, et al. 1994. Apolipoprotein E, ɛ4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer's disease: analysis of the 19q13.2 chromosomal region. Hum Mol Genet. 3:569–574.10.1093/hmg/3.4.569
   PubMed Web of Science ®Google Scholar
• Chaudhary R, Likidlilid A, Peerapatdit T, Tresukosol D, Srisuma S, Ratanamaneechat S, Sriratanasathavorn C. 2012. Apolipoprotein E gene polymorphism: effects on plasma lipids and risk of type 2 diabetes and coronary artery disease. Cardiovasc Diabetol. 11:36.10.1186/1475-2840-11-36
   PubMed Web of Science ®Google Scholar
• Chen JM, Huang CQ, Ai M, Kuang L. 2013. Circadian rhythm of TSH levels in subjects with Alzheimer’s disease (AD). Aging Clin Exp Res. 25:153–157.10.1007/s40520-013-0025-x
   PubMed Web of Science ®Google Scholar
• Chen HF, Chang-Quan H, You C, Wang ZR, Hui W, Liu QX, Si-Qing H. 2013. The circadian rhythm of arterial blood pressure in Alzheimer disease (AD) patients without hypertension. Blood Press. 22:101–105.10.3109/08037051.2012.733508
   PubMed Web of Science ®Google Scholar
• Eichner JE, Dunn ST, Perveen G, Thompson DM, Stewart KE, Stroehla BC. 2002. Apolipoprotein E polymorphism and cardiovascular disease: a HuGE review. Am J Epidemiol. 155:487–495.10.1093/aje/155.6.487
   PubMed Web of Science ®Google Scholar
• Ferreira DC, Costa TF, Aguiar SL, Marques AR, Ramos SA, Gomes KB, Alvarez-Leite JI.2011. Association of apoliprotein E polymorphisms and metabolic syndrome in subjects with extreme obesity. Clin Chim Acta. 412:1559–1562.10.1016/j.cca.2011.04.035
   PubMed Web of Science ®Google Scholar
• Haag T, Santos AS, De Angelo C, Srbek-Araujo AC, Sana DA, Morato RG, Salzano FM, Eizirik E. 2009. Development and testing of an optimized method for DNA-based identification of jaguar (Panthera onca) and puma (Puma concolor) faecal samples for use in ecological and genetic studies. Genetica. 136:505–512.10.1007/s10709-008-9347-6
   PubMed Web of Science ®Google Scholar
• Holt R, Barnby G, Maestrini E, Bacchelli E, Brocklebank D, Sousa I, Mulder EJ, Kantojärvi K, Järvelä I, Klauck SM, et al. 2010. Linkage and candidate gene studies of autism spectrum disorders in European populations. Eur J Hum Genet. 18:1013–1019.10.1038/ejhg.2010.69
   PubMed Web of Science ®Google Scholar
• Jayasinghe SS. 2012. Effects of acute organophosphate ingestion on cognitive function, assessed with the mini mental state examination. J Postgrad Med. 58:171–175.10.4103/0022-3859.101374
   PubMed Web of Science ®Google Scholar
• Jemaa R, Elasmi M, Naouali C, Feki M, Kallel A, Souissi M, Sanhaji H, Hadj Taïeb S, Souheil O, Kaabachi N. 2006. Apolipoprotein E polymorphism in the Tunisian population: frequency and effect on lipid parameters. Clin Biochem. 39:816–820.10.1016/j.clinbiochem.2006.04.018
   PubMed Web of Science ®Google Scholar
• Kivipelto M, Ngandu T, Fratiglioni L, Viitanen M, Kåreholt I, Winblad B, Helkala EL, Tuomilehto J, Soininen H, Nissinen A. 2005. Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease. Arch Neurol. 62:1556–1560.
   PubMed Web of Science ®Google Scholar
• Maillard P, Carmichael O, Fletcher E, Reed B, Mungas D, DeCarli C. 2012. Coevolution of white matter hyperintensities and cognition in the elderly. Neurology. 79:442–448.10.1212/WNL.0b013e3182617136
   PubMed Web of Science ®Google Scholar
• McHugh JE, Casey AM, Lawlor BA. 2011. Psychosocial correlates of aspects of sleep quality in community-dwelling Irish older adults. Aging Ment Health. 15:749–755.10.1080/13607863.2011.562180
   PubMed Web of Science ®Google Scholar
• Reitz C, Brayne C, Mayeux R. 2011. Epidemiology of Alzheimer disease. Nat Rev Neurol. 7:137–152.10.1038/nrneurol.2011.2
   PubMed Web of Science ®Google Scholar
• Rogalski EJ, Rademaker A, Harrison TM, Helenowski I, Johnson N, Bigio E, Mishra M, Weintraub S, Mesulam MM. 2011. ApoE E4 is a susceptibility factor in amnestic but not aphasic dementias. Alzheimer Dis Assoc Disord. 25:159–163.10.1097/WAD.0b013e318201f249
   PubMed Web of Science ®Google Scholar
• Scott EM, Carter AM, Grant PJ. 2008. Association between polymorphisms in the Clock gene, obesity and the metabolic syndrome in man. Int J Obes (Lond). 32:658–662.10.1038/sj.ijo.0803778
   PubMed Web of Science ®Google Scholar
• Sertic J, Juricic L, Ljubic H, Bozina T, Lovric J, Markeljevic J, Jelakovic B, Merkler M, Reiner Z. 2009. Variants of ESR1, APOE, LPL and IL-6 loci in young healthy subjects: association with lipid status and obesity. BMC Res Notes. 2:203.10.1186/1756-0500-2-203
   PubMedGoogle Scholar
• Sookoian S, Castaño G, Gemma C, Gianotti TF, Pirola CJ. 2007. Common genetic variations in CLOCK transcription factor are associated with nonalcoholic fatty liver disease. World J Gastroenterol. 13:4242–4248.10.3748/wjg.v13.i31.4242
   PubMed Web of Science ®Google Scholar
• Sookoian S, Gemma C, Gianotti TF, Burgueño A, Castaño G, Pirola CJ. 2008. Genetic variants of Clock transcription factor are associated with individual susceptibility to obesity. Am J Clin Nutr. 87:1606–1615.
   PubMed Web of Science ®Google Scholar
• Sookoian S, Gianotti TF, Burgueño A, Pirola CJ. 2010. Gene-gene interaction between serotonin transporter (SLC6A4) and CLOCK modulates the risk of metabolic syndrome in rotating shiftworkers. Chronobiol Int. 27:1202–1218.10.3109/07420528.2010.496913
   PubMed Web of Science ®Google Scholar
• Whitmer RA, Gunderson EP, Quesenberry CP Jr, Zhou J, Yaffe K. 2007. Body mass index in midlife and risk of Alzheimer disease and vascular dementia. Curr Alzheimer Res. 4:103–109.
   PubMed Web of Science ®Google Scholar
• Wu WS, Holmans P, Wavrant-DeVrièze F, Shears S, Kehoe P, Crook R, Booth J, Williams N, Pérez-Tur J, Roehl K, et al. 1998. Genetic studies on chromosome 12 in late-onset Alzheimer disease. JAMA. 280:619–622.10.1001/jama.280.7.619
   PubMed Web of Science ®Google Scholar
• Xu GY, Li Y, Zhang WZ. 2011. Gastric mammalian target of rapamycin signaling, hormone production and energy metabolism. World J Gastrointest Pathophysiol. 2:109–113.10.4291/wjgp.v2.i6.109
   PubMedGoogle Scholar
• Yong-Hong L, Xiao-Dong P, Chang-Quan H, Bo Y, Qing-Xiu L. 2013. Hypothalamic-pituitary-thyroid axis in patients with Alzheimer disease (AD). J Investig Med. 61:578–581.10.2310/JIM.0b013e318280aafb
   PubMed Web of Science ®Google Scholar
• Zonderman AB. 2005. Predicting Alzheimer’s disease in the Baltimore longitudinal study of aging. J Geriatr Psychiatry Neurol. 18:192–195.10.1177/0891988705281863
   PubMed Web of Science ®Google Scholar